STAGES Trial: Study of Adiposity, Growth and Endocrine Stages

Completed

Conditions studied: Obesity

In brief

The investigators propose to conduct a cross-sectional study of 60 participants who are 18-30 years of age to undergo research PET/CT. The purpose of this study is to investigate the relationships between Brown Adipose Tissue (BAT), the adiponectin/leptin (A/L) ratio, and components of the metabolic syndrome in young adults.

Key facts

Study ID

NCT01460784

Run by

University of Utah

People needed

575

Starts

2010-06-01

Expected to finish

2015-03-01

Last updated by the study team

2015-12-03

Who can join

Age: 18 and older, up to 30. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Males and females, 18-30 years of age at enrollment, who are obese (BMI greater or equal to 30 kg/m2, weight less than 159 kg) and healthy
• Without medications and endocrine/genetic disorders known to affect weight.
• Participants may have insulin resistance, impaired glucose tolerance, dyslipidemia, or hypertension.

You may not qualify if…

• Anyone who refuses participation.
• A genetic syndrome or other endocrine disorder known to cause obesity (Prader-Willi, Cushing Syndrome, Leptin deficiency, etc.).
• Use of the following medications: psychotropics, sulphonylurea, thiazolidinediones, insulin, glucocorticoids, anti-neoplastic agents, angiotensin receptor blocker, angiotensin-converting enzyme inhibitors.
• Pregnancy or history of pregnancy.
• Active infectious disease
• History of CVD or stroke during the previous 36 months
• Total cholesterol 300 mg/dl, triglycerides 400 mg/dl
• Blood pressure 140/90 mmHg
• Fasting plasma glucose 126 mg/dl.
• Diabetes mellitus, type 1 or 2.

Where it is running

• University of Utah — Salt Lake City, Utah, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.